• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

成人异基因造血干细胞移植后性腺功能减退症和男性健康的恢复。

Recovery from hypogonadism and male health in adult allogeneic stem cell transplantation.

机构信息

Department of Haemaotology/Oncology, University Medicine Greifswald, Greifswald, Germany.

Department of Urology and Paediatric Urology, Westpfalz-Hospital, Kaiserslautern, Germany.

出版信息

Eur J Haematol. 2018 Jun;100(6):584-591. doi: 10.1111/ejh.13052. Epub 2018 Apr 6.

DOI:10.1111/ejh.13052
PMID:29509972
Abstract

OBJECTIVE

There is a substantial lack of data about men`s health in adult allogeneic stem cell transplantation.

METHODS

We conducted prospective unicentric non-interventional clinical study on men's health with a follow-up time of 1 year.

RESULTS

Between 11/2013 and 12/2015, we were able to include 27 patients. AML was the most frequent underlying disease (25.9%), and we mainly used intermediate intense conditioning protocols (77.8%). Erectile dysfunction, loss of libido, and loss of efficiency were the most frequent symptoms of hypogonadism. At inclusion of the study, hypogonadism was already frequent. Primary hypogonadism was found in eight cases (29.6%) and secondary hypogonadism in one case (3.7%). We did not observe hypogonadism 6 months after inpatient treatment anymore, but there might still be the impairment of fertility because of still rising FSH levels at the end of the observation period. There were no significant associations of hypogonadism with myeloablative conditioning or kind of donor. Interestingly, there is a significant association with nicotine abuse (P = .049).

CONCLUSIONS

On the whole, male hypogonadism was found in one-third of the patients who underwent allogeneic stem cell transplantation.

摘要

目的

成人异基因造血干细胞移植中男性健康数据严重缺乏。

方法

我们进行了一项前瞻性、单中心、非干预性的男性健康临床研究,随访时间为 1 年。

结果

在 2013 年 11 月至 2015 年 12 月期间,我们共纳入 27 例患者。最常见的基础疾病是急性髓细胞白血病(AML,25.9%),我们主要使用中等强度的预处理方案(77.8%)。勃起功能障碍、性欲减退和效率下降是性腺功能减退最常见的症状。在研究纳入时,已经存在性腺功能减退。原发性性腺功能减退 8 例(29.6%),继发性性腺功能减退 1 例(3.7%)。我们在住院治疗后 6 个月不再观察到性腺功能减退,但由于在观察期末 FSH 水平仍升高,可能仍存在生育能力受损。性腺功能减退与清髓性预处理或供者类型无显著相关性。有趣的是,它与尼古丁滥用显著相关(P=0.049)。

结论

在接受异基因造血干细胞移植的患者中,三分之一存在男性性腺功能减退。

相似文献

1
Recovery from hypogonadism and male health in adult allogeneic stem cell transplantation.成人异基因造血干细胞移植后性腺功能减退症和男性健康的恢复。
Eur J Haematol. 2018 Jun;100(6):584-591. doi: 10.1111/ejh.13052. Epub 2018 Apr 6.
2
[Allogeneic stem cell transplantation following non-myeloablative conditioning: favorable results in 21 high risk patients with hematological malignancies treated in the Utrecht University Medical Center, the Netherlands].非清髓性预处理后的异基因干细胞移植:荷兰乌得勒支大学医学中心治疗的21例血液系统恶性肿瘤高危患者的良好结果
Ned Tijdschr Geneeskd. 2003 Nov 22;147(47):2328-32.
3
Gonadal status in long-term male survivors of childhood cancer.儿童癌症长期存活男性患者的性腺状态
J Cancer Res Clin Oncol. 2016 May;142(5):1127-32. doi: 10.1007/s00432-016-2124-5. Epub 2016 Feb 10.
4
Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.异基因反应性作为血液系统恶性肿瘤治疗的治疗原则。非清髓性预处理的异基因造血细胞移植的临床和免疫学方面的研究。
Dan Med Bull. 2007 May;54(2):112-39.
5
Late-onset hypogonadism.迟发性性腺功能减退症。
Med Clin North Am. 2011 May;95(3):507-23, x. doi: 10.1016/j.mcna.2011.03.001.
6
Non-myeloablative allogeneic peripheral stem cell transplantation for multiple myeloma.非清髓性异基因外周血干细胞移植治疗多发性骨髓瘤
Hong Kong Med J. 2004 Apr;10(2):77-83.
7
Development of and Recovery from Secondary Hypogonadism in Aging Men: Prospective Results from the EMAS.老年男性继发性性腺功能减退的发生与恢复:欧洲男性衰老研究(EMAS)的前瞻性结果
J Clin Endocrinol Metab. 2015 Aug;100(8):3172-82. doi: 10.1210/jc.2015-1571. Epub 2015 May 22.
8
Allogeneic hematopoietic cell transplantation without myeloablative conditioning for patients with advanced hematologic malignancies.对晚期血液系统恶性肿瘤患者进行非清髓性预处理的异基因造血细胞移植。
Cytotherapy. 2001;3(4):253-60. doi: 10.1080/146532401317070880.
9
Post-transplantation Cyclophosphamide and Sirolimus after Haploidentical Hematopoietic Stem Cell Transplantation Using a Treosulfan-based Myeloablative Conditioning and Peripheral Blood Stem Cells.使用白消安为基础的清髓性预处理方案及外周血干细胞进行单倍体相合造血干细胞移植后环磷酰胺和西罗莫司的应用
Biol Blood Marrow Transplant. 2015 Aug;21(8):1506-14. doi: 10.1016/j.bbmt.2015.04.025. Epub 2015 May 19.
10
Comparative outcome of reduced intensity and myeloablative conditioning regimen in HLA identical sibling allogeneic hematopoietic stem cell transplantation for acute leukemia patients: a single center experience.急性白血病患者 HLA 全相合同胞异基因造血干细胞移植中,减低剂量预处理方案与清髓性预处理方案的比较结果:单中心经验
Transfus Apher Sci. 2013 Dec;49(3):590-9. doi: 10.1016/j.transci.2013.07.030. Epub 2013 Aug 8.

引用本文的文献

1
Impact of haematopoietic stem cell transplantation for benign and malignant haematologic and non-haematologic disorders on fertility: a systematic review and meta-analysis.造血干细胞移植治疗良性和恶性血液系统及非血液系统疾病对生育能力的影响:一项系统评价和荟萃分析。
Bone Marrow Transplant. 2025 May;60(5):645-672. doi: 10.1038/s41409-025-02520-6. Epub 2025 Feb 26.
2
Male-specific late effects in adult hematopoietic cell transplantation recipients: a systematic review from the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research and Transplant Complications Working Party of the European Society of Blood and Marrow Transplantation.成年造血细胞移植受者的男性特异性晚期效应:来自国际血液和骨髓移植研究中心晚期效应和生活质量工作组以及欧洲血液和骨髓移植学会移植并发症工作组的系统评价。
Bone Marrow Transplant. 2022 Jul;57(7):1150-1163. doi: 10.1038/s41409-022-01591-z. Epub 2022 May 6.
3
Sexual and Emotional Health after Allogeneic Hematopoietic Cell Transplantation: A Comprehensive Review and Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC).异基因造血细胞移植后的性健康与情绪健康:来自法语国家骨髓移植与细胞治疗协会(SFGM-TC)的全面综述及指南
J Clin Med. 2022 Feb 23;11(5):1196. doi: 10.3390/jcm11051196.
4
Male-Specific Late Effects in Adult Hematopoietic Cell Transplantation Recipients: A Systematic Review from the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research and Transplant Complications Working Party of the European Society of Blood and Marrow Transplantation.男性特有的造血干细胞移植受者晚期效应:来自国际血液和骨髓移植研究中心晚期效应和生活质量工作组以及欧洲血液和骨髓移植学会移植并发症工作组的系统评价。
Transplant Cell Ther. 2022 Jun;28(6):335.e1-335.e17. doi: 10.1016/j.jtct.2021.10.013. Epub 2021 Oct 29.